Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.
Acute coronary syndrome
Antithrombotic treatment
Chronic coronary syndrome
Coronary artery disease
Percutaneous coronary intervention
Journal
European heart journal. Cardiovascular pharmacotherapy
ISSN: 2055-6845
Titre abrégé: Eur Heart J Cardiovasc Pharmacother
Pays: England
ID NLM: 101669491
Informations de publication
Date de publication:
29 07 2023
29 07 2023
Historique:
received:
15
03
2023
revised:
15
04
2023
accepted:
27
04
2023
medline:
31
7
2023
pubmed:
30
4
2023
entrez:
30
4
2023
Statut:
ppublish
Résumé
Multiple guidelines and consensus papers have addressed the role of antithrombotic strategies in patients with established coronary artery disease (CAD). Since evidence and terminology continue to evolve, the authors undertook a consensus initiative to guide clinicians to select the optimal antithrombotic regimen for each patient. The aim of this document is to provide an update for clinicians on best antithrombotic strategies in patients with established CAD, classifying each treatment option in relation to the number of antithrombotic drugs irrespective of whether the traditional mechanism of action is expected to mainly inhibit platelets or coagulation cascade. With the aim to reach comprehensiveness of available evidence, we systematically reviewed and performed meta-analyses by means of both direct and indirect comparisons to inform the present consensus document.
Identifiants
pubmed: 37120728
pii: 7147298
doi: 10.1093/ehjcvp/pvad032
doi:
Substances chimiques
Fibrinolytic Agents
0
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-496Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.